Browse the latest stories and reports on MSF from various media outlets.

Country/Region

May 06, 2015

PBS Frontline examines the flawed response to the Ebola outbreak in West Africa. MSF's Joanne Liu, Stefan Liljegren, Hilde de Clerck, Michel Van Herp, Marc Poncin and Brett Adamson are interviewed. View external media.

March 20, 2015

A newly developed tablet computer, which can be dipped in chlorine solution, is helping MSF collect patient data in its Ebola response. View external media.

March 04, 2015

MSF's Séverine Caluwaerts writes about the need for emergency obstetric care worldwide. View external media.

October 28, 2014

MSF-USA's executive director Sophie Delaunay speaks with CNN's Anderson Cooper about the problems with quarantines for aid workers returning from the Ebola outbreak. View external media.

September 10, 2014

A half-hour documentary on MSF's Ebola center in Kailahun, Sierra Leone, as the Ebola epidemic grows further out of control. View external media.

June 28, 2013

A House subcommittee held a hearing on international trade disputes with India. Most of the event was devoted to U.S. drug company Pfizer's complaints about Indian policies that have fostered the country's billion-dollar generics industry.

April 02, 2013

  A landmark ruling by India's Supreme Court underscores the need for patients to have access to generic medications at affordable prices, according to MSF's Jennifer Cohn.

February 19, 2013

  MSF's Betty Raney describes how she and her team reduced maternal deaths in Sierra Leone through emergency obstetric care.

January 18, 2013

  Betty Raney and Yvonne Nzomukunda describe MSF's efforts to prevent maternal and infant deaths in childbirth in Sierra Leone, where the health system is still recovering from war.  

August 21, 2012

Novartis AG goes to India's Supreme Court on Wednesday to seek patent protection for its blockbuster cancer drug Glivec in a case that could deliver far-reaching ramifications for multinational pharmaceutical companies operating in India.... Novartis's critics, including Médecins Sans Frontières [Doctors Without Borders], say that if the company prevails, it could set a legal precedent that allows pharmaceutical giants to patent a range of drugs in India that are now available from generic producers, including HIV medicines. That would demolish a thriving low-cost industry and lead to higher prices, not just in India, they say, but elsewhere in the developing world where India is a major exporter of drugs.

Pages